Nuclear entry of hyperbranched polylysine nanoparticles into cochlear cells.

Weikai Zhang1, Ya Zhang, Marian Löbler

  • 1Department of Otolaryngology, University of Tampere, Medical School, Finland.

Summary

Hyperbranched polylysine nanoparticles (HPNPs) show potential for treating hearing loss by entering cochlear cells. These nanoparticles successfully delivered genes in both lab and animal studies, offering a promising nonviral gene therapy vector.